PL3522904T3 - Ciekła kompozycja do stosowania w leczeniu refluksu żołądkowo- przełykowego - Google Patents

Ciekła kompozycja do stosowania w leczeniu refluksu żołądkowo- przełykowego

Info

Publication number
PL3522904T3
PL3522904T3 PL17797183T PL17797183T PL3522904T3 PL 3522904 T3 PL3522904 T3 PL 3522904T3 PL 17797183 T PL17797183 T PL 17797183T PL 17797183 T PL17797183 T PL 17797183T PL 3522904 T3 PL3522904 T3 PL 3522904T3
Authority
PL
Poland
Prior art keywords
treatment
liquid composition
gastroesophageal reflux
gastroesophageal
reflux
Prior art date
Application number
PL17797183T
Other languages
English (en)
Inventor
Andrea BIFFI
Sara SALA
Original Assignee
Sofar Swiss Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar Swiss Sa filed Critical Sofar Swiss Sa
Publication of PL3522904T3 publication Critical patent/PL3522904T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL17797183T 2016-10-10 2017-10-10 Ciekła kompozycja do stosowania w leczeniu refluksu żołądkowo- przełykowego PL3522904T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102016000101413A IT201600101413A1 (it) 2016-10-10 2016-10-10 Composizione liquida per uso nel trattamento del reflusso gastroesofageo
PCT/IB2017/056254 WO2018069832A1 (en) 2016-10-10 2017-10-10 Liquid composition for use in the treatment of gastroesophageal reflux
EP17797183.5A EP3522904B1 (en) 2016-10-10 2017-10-10 Liquid composition for use in the treatment of gastroesophageal reflux

Publications (1)

Publication Number Publication Date
PL3522904T3 true PL3522904T3 (pl) 2022-02-07

Family

ID=57960706

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17797183T PL3522904T3 (pl) 2016-10-10 2017-10-10 Ciekła kompozycja do stosowania w leczeniu refluksu żołądkowo- przełykowego

Country Status (9)

Country Link
US (2) US11337992B2 (pl)
EP (1) EP3522904B1 (pl)
DK (1) DK3522904T3 (pl)
ES (1) ES2900565T3 (pl)
HU (1) HUE057257T2 (pl)
IT (1) IT201600101413A1 (pl)
PL (1) PL3522904T3 (pl)
PT (1) PT3522904T (pl)
WO (1) WO2018069832A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201800004332A1 (it) * 2018-04-09 2019-10-09 Composizione liquida per uso nel trattamento della mucosa del tratto oro-faringo-laringo-esofageo
IT201900008409A1 (it) * 2019-06-07 2020-12-07 Vivatis Pharma Gmbh Individuazione e selezione di un materiale di partenza vegetale di condroitina solfato e acido ialuronico vegetali, e trasformazione di tale materiale di partenza vegetale per l’ottenimento di ingredienti per utilizzo in alimenti, integratori, dispositivi medici o farmaci
IT202000022477A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
IT202000022471A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
IT202100021995A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee
IT202100021992A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147418A (ja) 1984-08-13 1986-03-07 Seikagaku Kogyo Co Ltd ヒアルロン酸含有胃粘膜保護剤
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
WO2004044009A1 (en) 2002-11-13 2004-05-27 Cargill, Incorporated Isolating chondroitin sulfate
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2335529T3 (es) * 2005-07-21 2010-03-29 Kabushiki Kaisha Yakult Honsha Bacteria nueva que pertenece al genero bifidobacterium y utilizacion de la misma.
US20090208588A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown GERD carbohydrate compositions
PT2296670E (pt) * 2008-05-13 2013-03-25 Apharm Srl Utilização oral de glicosaminoglicana e composições
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
US8362025B2 (en) * 2008-12-22 2013-01-29 Hydra Biosciences, Inc. Compositions useful for treating disorders related to TRPA1
PT2435021E (pt) 2009-05-25 2013-09-30 Sofar Swiss Sa Utilização de uma combinação fixa de glicosaminoglicano e composição mastigável compreendendo a referida combinação fixa
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110038945A1 (en) * 2009-08-13 2011-02-17 Gear Gavin M Orally ingestable medicament and method for treating a heartburn inducing event or an acid reflux episode in a living human subject
WO2014078623A2 (en) 2012-11-15 2014-05-22 Brandeis University Tethering cysteine residues using cyclic disulfides
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EA037070B9 (ru) 2015-10-01 2021-03-29 Афарм С.Р.Л. Комбинация гликозаминогликанов и антацидного агента и содержащая ее композиция
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201700124424A1 (it) 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali
IT201700124434A1 (it) 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD.

Also Published As

Publication number Publication date
US20220265701A1 (en) 2022-08-25
PT3522904T (pt) 2021-12-13
US11337992B2 (en) 2022-05-24
ES2900565T3 (es) 2022-03-17
EP3522904B1 (en) 2021-09-15
DK3522904T3 (da) 2021-12-06
US11690867B2 (en) 2023-07-04
IT201600101413A1 (it) 2018-04-10
WO2018069832A1 (en) 2018-04-19
EP3522904A1 (en) 2019-08-14
US20190262388A1 (en) 2019-08-29
HUE057257T2 (hu) 2022-05-28

Similar Documents

Publication Publication Date Title
IL247841A0 (en) Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma
PL3522904T3 (pl) Ciekła kompozycja do stosowania w leczeniu refluksu żołądkowo- przełykowego
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
IL251904B (en) Epilimod for use in the treatment of melanoma
ZA202001988B (en) Liquid personal cleansing composition
IL263804A (en) Wnt inhibitors for use in the treatment of fibrosis
PL3423060T3 (pl) Imatynib do stosowania w leczeniu udaru mózgu
PL3160464T3 (pl) 6-hydroksybuspiron do stosowania w leczeniu zaburzeń ruchowych
HK1225994A1 (zh) 用於治療過敏性病症的組合物
HK1256164A1 (zh) 用於治療神經膠質瘤的製劑
IL251345B (en) Preparations for use in the treatment of peri-implantitis
EP3440052C0 (en) COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB2581876B (en) Compositions for use in the treatment of endometrial disorder
LT3548006T (lt) Kompozicija, skirta žarnyno pakitimams gydyti
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
TH182881B (th) องค์ประกอบสำหรับการใช้ในการบำบัดภาวะภูมิแพ้
ZA201404780B (en) Composition for use in treatment of diabetes